Compare Wockhardt with Divis Laboratories - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WOCKHARDT vs DIVIS LABORATORIES - Comparison Results

WOCKHARDT     Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

DIVIS LABORATORIES 
   Change

Established in the year 1990, Divi's Laboratories has been focusing on CRAMS and is an established player in the custom chemical synthesis (CCS) and API/Intermediate segment. Around 50% of Divi's revenues are derived from custom manufacturing for glo... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WOCKHARDT DIVIS LABORATORIES WOCKHARDT/
DIVIS LABORATORIES
 
P/E (TTM) x -48.1 41.7 - View Chart
P/BV x 1.1 8.3 12.9% View Chart
Dividend Yield % 0.0 0.7 0.5%  

Financials

 WOCKHARDT   DIVIS LABORATORIES
EQUITY SHARE DATA
    WOCKHARDT
Mar-18
DIVIS LABORATORIES
Mar-19
WOCKHARDT/
DIVIS LABORATORIES
5-Yr Chart
Click to enlarge
High Rs1,0121,639 61.7%   
Low Rs5321,115 47.7%   
Sales per share (Unadj.) Rs355.9186.3 191.0%  
Earnings per share (Unadj.) Rs-60.351.0 -118.3%  
Cash flow per share (Unadj.) Rs-46.857.3 -81.6%  
Dividends per share (Unadj.) Rs0.0116.00 0.1%  
Dividend yield (eoy) %01.2 0.1%  
Book value per share (Unadj.) Rs257.8261.8 98.5%  
Shares outstanding (eoy) m110.63265.47 41.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.27.4 29.3%   
Avg P/E ratio x-12.827.0 -47.4%  
P/CF ratio (eoy) x-16.524.0 -68.7%  
Price / Book Value ratio x3.05.3 56.9%  
Dividend payout %031.4 -0.1%   
Avg Mkt Cap Rs m85,379365,592 23.4%   
No. of employees `0006.311.8 52.8%   
Total wages/salary Rs m9,3715,423 172.8%   
Avg. sales/employee Rs Th6,295.04,175.1 150.8%   
Avg. wages/employee Rs Th1,498.3457.7 327.3%   
Avg. net profit/employee Rs Th-1,066.31,141.8 -93.4%   
INCOME DATA
Net Sales Rs m39,36949,463 79.6%  
Other income Rs m1,2021,556 77.3%   
Total revenues Rs m40,57151,019 79.5%   
Gross profit Rs m1818,718 0.1%  
Depreciation Rs m1,4951,689 88.5%   
Interest Rs m2,55535 7,299.7%   
Profit before tax Rs m-2,83018,551 -15.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-3,5820-   
Tax Rs m2575,023 5.1%   
Profit after tax Rs m-6,66913,527 -49.3%  
Gross profit margin %037.8 0.1%  
Effective tax rate %-9.127.1 -33.5%   
Net profit margin %-16.927.3 -61.9%  
BALANCE SHEET DATA
Current assets Rs m33,79646,501 72.7%   
Current liabilities Rs m26,9178,468 317.9%   
Net working cap to sales %17.576.9 22.7%  
Current ratio x1.35.5 22.9%  
Inventory Days Days79131 60.7%  
Debtors Days Days8986 103.9%  
Net fixed assets Rs m39,66425,797 153.8%   
Share capital Rs m553531 104.2%   
"Free" reserves Rs m27,96868,962 40.6%   
Net worth Rs m28,52269,493 41.0%   
Long term debt Rs m21,7310-   
Total assets Rs m81,62080,383 101.5%  
Interest coverage x-0.1531.0 -0.0%   
Debt to equity ratio x0.80-  
Sales to assets ratio x0.50.6 78.4%   
Return on assets %-5.016.9 -29.9%  
Return on equity %-23.419.5 -120.1%  
Return on capital %-7.726.7 -28.7%  
Exports to sales %00-   
Imports to sales %024.6 0.0%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNA12,187 0.0%   
Fx inflow Rs m9,80741,238 23.8%   
Fx outflow Rs m1,78912,405 14.4%   
Net fx Rs m8,01928,833 27.8%   
CASH FLOW
From Operations Rs m6849,543 7.2%  
From Investments Rs m6,302-6,854 -92.0%  
From Financial Activity Rs m-7,695-2,459 312.9%  
Net Cashflow Rs m-664230 -289.2%  

Share Holding

Indian Promoters % 74.5 52.0 143.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 2.3 11.8 19.5%  
FIIs % 7.7 19.0 40.5%  
ADR/GDR % 0.1 0.0 -  
Free float % 15.4 17.2 89.5%  
Shareholders   67,757 31,796 213.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WOCKHARDT With:   J.B.CHEMICALS  SUVEN LIFESCIENCES  CIPLA  CADILA HEALTHCARE  VENUS REMEDIES  

Compare WOCKHARDT With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 466 Points Higher; Energy, Auto and Realty Stocks Rally(Closing)

Indian share markets extended gains as the session progressed and ended on a strong note, driven by automobile stocks and index heavyweight Reliance Industries.

Related Views on News

DIVIS LABORATORIES Announces Quarterly Results (4QFY20); Net Profit Up 35.4% (Quarterly Result Update)

Jun 8, 2020 | Updated on Jun 8, 2020

For the quarter ended March 2020, DIVIS LABORATORIES has posted a net profit of Rs 4 bn (up 35.4% YoY). Sales on the other hand came in at Rs 14 bn (up 9.5% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

DIVIS LABORATORIES Announces Quarterly Results (3QFY20); Net Profit Down 4.9% (Quarterly Result Update)

Feb 6, 2020 | Updated on Feb 6, 2020

For the quarter ended December 2019, DIVIS LABORATORIES has posted a net profit of Rs 4 bn (down 4.9% YoY). Sales on the other hand came in at Rs 14 bn (up 3.5% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

WOCKHARDT Announces Quarterly Results (3QFY20); Net Profit Up 125.0% (Quarterly Result Update)

Jan 28, 2020 | Updated on Jan 28, 2020

For the quarter ended December 2019, WOCKHARDT has posted a net profit of Rs 192 m (up 125.0% YoY). Sales on the other hand came in at Rs 9 bn (down 16.9% YoY). Read on for a complete analysis of WOCKHARDT's quarterly results.

DIVIS LABORATORIES Announces Quarterly Results (2QFY20); Net Profit Down 10.3% (Quarterly Result Update)

Nov 11, 2019 | Updated on Nov 11, 2019

For the quarter ended September 2019, DIVIS LABORATORIES has posted a net profit of Rs 4 bn (down 10.3% YoY). Sales on the other hand came in at Rs 14 bn (up 12.5% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

DIVIS LABORATORIES 2018-19 Annual Report Analysis (Annual Result Update)

Oct 10, 2019 | Updated on Oct 10, 2019

Here's an analysis of the annual report of DIVIS LABORATORIES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of DIVIS LABORATORIES. Also includes updates on the valuation of DIVIS LABORATORIES.

More Views on News

Most Popular

How to Find the Best Stocks for Day Trading - 1(Fast Profits Daily)

Jul 2, 2020

In the first of two videos, I'll show you how to identify the best stocks for intraday trading.

Be Prepared to Profit from the Coming Crash in Oil Prices(Fast Profits Daily)

Jun 25, 2020

The stability in crude oil prices will not last much longer. Be ready to make fast profits when the time comes to short crude.

Two Agri Stocks Are Likely to Outperform Even in this Market(Profit Hunter)

Jul 2, 2020

Why we have recommended two agriculture stocks for our Hidden Treasure subscribers. Read on...

Tata Motors Tripled in 18 Months but You Can Do Even Better. Here's How...(Profit Hunter)

Jun 24, 2020

Rahul is ready for a repeat of his famous 2008 Tata Motors call.

More

India's #1 Trader
Reveals His Secrets

The Secret to Increasing Your Trading Profits Today
Get this Special Report, The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

WOCKHARDT SHARE PRICE


Jul 6, 2020 (Close)

TRACK WOCKHARDT

  • Track your investment in WOCKHARDT with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE WOCKHARDT WITH

MARKET STATS